Genome-wide association meta-analyses combining multiple risk phenotypes provide insights into the genetic architecture of cutaneous melanoma susceptibility
Maria Teresa Landi(National Institutes of Health), D. Timothy Bishop(University of Leeds), Stuart MacGregor(QIMR Berghofer Medical Research Institute), Mitchell J. Machiela(National Institutes of Health), Alexander Stratigos(National and Kapodistrian University of Athens), Paola Ghiorzo(Ospedale Policlinico San Martino), Myriam Brossard(Délégation Paris 5), Donato Calista(Ospedale “M. Bufalini” di Cesena), Jiyeon Choi(National Institutes of Health), Maria Concetta Fargnoli(University of L'Aquila), Tongwu Zhang(National Institutes of Health), Monica Rodolfo(Fondazione IRCCS Istituto Nazionale dei Tumori), Adam J. Trower(University of Leeds), Chiara Menin(Istituto Oncologico Veneto), J. Julian Martinez(Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana), Andreas Hadjisavvas(Cyprus Institute of Neurology and Genetics), Lei Song(National Institutes of Health), Irene Stefanaki(National and Kapodistrian University of Athens), Richard A. Scolyer(The University of Sydney), Rose Yang(National Institutes of Health), Alisa M. Goldstein(National Institutes of Health), Míriam Potrony(Hospital Clínic de Barcelona), Katerina Kypreou(National and Kapodistrian University of Athens), Lorenza Pastorino(Ospedale Policlinico San Martino), Paola Queirolo(Ospedale Policlinico San Martino), Cristina Pellegrini(University of L'Aquila), Laura Cattaneo(Ospedale Papa Giovanni XXIII), Matthew Zawistowski(University of Michigan), Pol Giménez‐Xavier(Hospital Clínic de Barcelona), A. L. Rodriguez(Fundación Instituto Valenciano de Oncología), Lisa Elefanti(Istituto Oncologico Veneto), Siranoush Manoukian(Fondazione IRCCS Istituto Nazionale dei Tumori), Licia Rivoltini(Fondazione IRCCS Istituto Nazionale dei Tumori), Blair H. Smith(University of Dundee), Maria A. Loizidou(Cyprus Institute of Neurology and Genetics), Laura Del Regno(Agostino Gemelli University Polyclinic), Daniela Massi(University of Florence), Mario Mandalà(Ospedale Papa Giovanni XXIII), Kiarash Khosrotehrani(The University of Queensland), Lars A. Akslen(Haukeland University Hospital), Christopher I. Amos(Dartmouth College), Per Arne Andresen(Oslo University Hospital), Marie‐Françoise Avril(Délégation Paris 5), Esther Azizi(Tel Aviv University), H. Peter Soyer(Translational Research Institute), Véronique Bataille(King's College London), Bruna Dalmasso(Ospedale Policlinico San Martino), Lisa Bowdler(QIMR Berghofer Medical Research Institute), Kathryn P. Burdon(University of Tasmania), Wei V. Chen(The University of Texas MD Anderson Cancer Center), Veryan Codd(University of Leicester), Jamie E. Craig(Flinders University), Tadeusz Dębniak(International Hereditary Cancer Center), Mario Falchi(King's College London), Shenying Fang(The University of Texas MD Anderson Cancer Center), Eitan Friedman(Tel Aviv University), Sarah Simi(University of Florence), Pilar Galán(Conservatoire National des Arts et Métiers), Zaida García‐Casado(Fundación Instituto Valenciano de Oncología), Elizabeth M. Gillanders(National Institutes of Health), Scott D. Gordon(QIMR Berghofer Medical Research Institute), Adèle C. Green(QIMR Berghofer Medical Research Institute), Nelleke A. Gruis(Leiden University Medical Center), Johan Hansson(Karolinska University Hospital), Mark Harland(University of Leeds), Jessica Harris(Translational Research Institute), Per Helsing(Oslo University Hospital), Anjali K. Henders(The University of Queensland), Marko Hočevar(Institute of Oncology Ljubljana), Veronica Höiom(Karolinska University Hospital), David J. Hunter(Harvard University), Christian Ingvar(Lund University), Rajiv Kumar(German Cancer Research Center), Julie Lang(University of Glasgow), G.M. Lathrop(McGill University and Génome Québec Innovation Centre), Jeffrey E. Lee(The University of Texas MD Anderson Cancer Center), Xin Li(Indiana University Health), Jan Lubiński(International Hereditary Cancer Center), Rona M. MacKie(Public Health Scotland), M. Malt(QIMR Berghofer Medical Research Institute), Josep Malvehy(Hospital Clínic de Barcelona), Kerrie McAloney(QIMR Berghofer Medical Research Institute), Hamida Mohamdi(Délégation Paris 5), Anders Molven(Haukeland University Hospital), Eric K. Moses(The University of Western Australia), Rachel Ε. Neale(QIMR Berghofer Medical Research Institute), Srdjan Novaković(Institute of Oncology Ljubljana), Dale R. Nyholt(Queensland University of Technology), Håkan Olsson(Lund University), Nick Orr(Institute of Cancer Research), Lars G. Fritsche(University of Michigan), Joan Anton Puig‐Butille(Hospital Clínic de Barcelona), Abrar A. Qureshi(Brown University), Graham Radford‐Smith(The University of Queensland), Juliette A. Randerson‐Moor(University of Leeds), Celia Requena(Fundación Instituto Valenciano de Oncología), Casey Rowe(The University of Queensland), Nilesh J. Samani(University of Leicester), Marianna Sanna(King's College London), Dirk Schadendorf(German Cancer Research Center), Hans‐Joachim Schulze(University of Münster), Lisa A. Simms(QIMR Berghofer Medical Research Institute), B. Mark Smithers(The University of Queensland), Fengju Song(Tianjin Medical University Cancer Institute and Hospital), Anthony J. Swerdlow(Institute of Cancer Research), Nienke van der Stoep(Leiden University Medical Center), Nicole A. Kukutsch(Leiden University Medical Center), Alessia Visconti(King's College London), Leanne Wallace(The University of Queensland), Sarah V. Ward(Memorial Sloan Kettering Cancer Center), Lawrie Wheeler(Translational Research Institute), Richard A. Sturm(Translational Research Institute), Amy Hutchinson(Leidos (United States)), Kristine Jones(Leidos (United States)), Michael Malasky(Leidos (United States)), Aurélie Vogt(Leidos (United States)), Weiyin Zhou(Leidos (United States)), Karen A. Pooley(University of Cambridge), David E. Elder(University of Pennsylvania), Jiali Han(Indiana University Health), Belynda Hicks(Leidos (United States)), Nicholas K. Hayward(QIMR Berghofer Medical Research Institute), Peter A. Kanetsky(Moffitt Cancer Center), Chad M. Brummett(University of Michigan), Grant W. Montgomery(The University of Queensland), Catherine M. Olsen(QIMR Berghofer Medical Research Institute), Caroline Hayward(Western General Hospital), Alison M. Dunning(University of Cambridge), Nicholas G. Martin(QIMR Berghofer Medical Research Institute), Εvangelos Εvangelou(University of Ioannina), Graham J. Mann(Australian National University), Georgina V. Long(The University of Sydney), Paul D.P. Pharoah(University of Cambridge), Douglas F. Easton(University of Cambridge), Jennifer H. Barrett(University of Leeds), Anne Ε. Cust(The University of Sydney), Gonçalo R. Abecasis(University of Michigan), David L. Duffy(Translational Research Institute), David C. Whiteman(QIMR Berghofer Medical Research Institute), Helen Gogas(National and Kapodistrian University of Athens), Arcangela De Nicolo(Istituto Oncologico Veneto), Margaret A. Tucker(National Institutes of Health), Julia Newton‐Bishop(University of Leeds), Q-MEGA and QTWIN Investigators(Agostino Gemelli University Polyclinic), ATHENS Melanoma Study Group(National Institutes of Health), 23andMe(Délégation Paris 5), The SDH Study Group(National Institutes of Health), IBD Investigators(Hospital Clínic de Barcelona), Essen-Heidelberg Investigators(Fundación Instituto Valenciano de Oncología), AMFS Investigators(National Institutes of Health), Ketty Peris(University of Leeds), Stephen J. Chanock(National Institutes of Health), Florence Démenais(Délégation Paris 5), Kevin M. Brown(National Institutes of Health), Susana Puig(Hospital Clínic de Barcelona), Eduardo Nagore(Fundación Instituto Valenciano de Oncología), Jianxin Shi(National Institutes of Health), Mark M. Iles(University of Leeds), Matthew H. Law(QIMR Berghofer Medical Research Institute)
Cited by 237Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis